Exero Medical Raises Significant Funding to Expand Operations
Exero Medical, a dynamic company specializing in the early detection of post-operative complications, has achieved a remarkable milestone by securing up to $12.7 million in seed financing. This funding is intended to further support the company’s FDA pivotal trials and the introduction of its cutting-edge xBar system in the U.S. market.
Funding Overview
The financing round encompasses $10 million in upfront investments, complemented by milestone-based warrants and $2.7 million in non-dilutive grants. This infusion of capital aims to expedite Exero's clinical programs and regulatory approvals.
The xBar System: A Game Changer
The xBar system signifies a transformative approach to post-operative care, utilizing sensors strategically placed at surgical sites. These sensors collect invaluable data which aids healthcare providers in the early detection of significant, life-threatening complications that may arise post-surgery. Research indicates that mortality rates for patients with severe complications from gastrointestinal surgery can reach as high as 20%. Therefore, the introduction of this technology could significantly improve patient outcomes.
Investor Insights
Raissa Hacohen, Managing Partner at Longevity Venture Partners, expressed enthusiasm over leading this investment round, stating, "We were thrilled to support Exero as we believe in the potential to revolutionize health data collection. Our commitment is to enhance the efficiency of healthcare delivery systems and ultimately improve patient care by integrating innovative medical technologies."
The Importance of Real-Time Data
Mark Kolb from Tech Council Ventures highlighted the potential impact of the xBar system, noting that this breakthrough technology could reshape post-operative care by providing crucial real-time data. Kolb acknowledged the role of such advancements in saving lives and reducing overall healthcare costs. "Tech Council Ventures stands behind Exero's mission and is excited to support their entry into the U.S. market," he stated.
Establishing a U.S. Presence
As part of its strategy, Exero Medical has set up its new headquarters at Scitech Scity, within the Liberty Science Center. This location will function as a pivotal hub for the company’s clinical program, regulatory processes, and the launch of the xBar system, facilitating collaboration and innovation in a conducive environment.
Company Mission and Vision
Exero Medical is committed to empowering healthcare providers with access to high-quality, actionable data on post-operative tissue healing. This mission is centered on improving patient outcomes and reducing healthcare costs. The xBar system, which has been recognized with Breakthrough Device Designation by the FDA, is a testament to the company’s dedication to enhancing medical technology.
About Exero Medical
Founded in 2018 by MEDX Xelerator, Exero Medical is supported by various esteemed backers, including the Israeli Innovation Authority, Tech Council Ventures, Longevity Venture Partners, Edge Medical Ventures, Consensus Business Group, Unorthodox Ventures, and Clalit Health Services, the largest health maintenance organization in Israel. It is important to note that while the xBar system has advanced significantly in its development, it remains classified for investigational use and is not currently approved for sale in the United States.
Frequently Asked Questions
1. What is the purpose of the xBar system?
The xBar system is designed to collect data from surgical sites to assist healthcare providers in detecting post-operative complications at an early stage.
2. How much funding did Exero Medical secure?
Exero Medical secured up to $12.7 million in funding, which includes upfront investments and non-dilutive grants.
3. Where is Exero Medical's new U.S. headquarters located?
The new headquarters is located at Scitech Scity in the Liberty Science Center, which will serve as a hub for Exero's operations.
4. What are the expected benefits of the xBar system?
The xBar system aims to improve patient outcomes by providing real-time data that can lead to early detection of severe post-operative complications, ultimately saving lives and reducing costs.
5. When was Exero Medical founded?
Exero Medical was founded in 2018 by MEDX Xelerator, specializing in medical technology and innovation.
